Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Lorlatinib: an additional option for ALK-positive non-small cell lung cancer?

Mogenet A, Tomasini P, Greillier L, Barlesi F.

Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S383-S386. doi: 10.21037/tlcr.2019.05.10. No abstract available.

2.

Structural equation modelling exploration of the key pathophysiological processes involved in cardiac surgery-related acute kidney injury in infants.

Bojan M, Basto Duarte MC, Ermak N, Lopez-Lopez V, Mogenet A, Froissart M.

Crit Care. 2016 Jun 5;20(1):171. doi: 10.1186/s13054-016-1350-1.

3.

Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.

Bourget P, Amin A, Chandesris MO, Vidal F, Merlette C, Hirsch I, Cabaret L, Carvalhosa A, Mogenet A, Frenzel L, Damaj G, Lortholary O, Hermine O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jan 1;944:175-81. doi: 10.1016/j.jchromb.2013.11.003. Epub 2013 Nov 15.

PMID:
24316764
4.

Predictive performance of urine neutrophil gelatinase-associated lipocalin for dialysis requirement and death following cardiac surgery in neonates and infants.

Bojan M, Vicca S, Lopez-Lopez V, Mogenet A, Pouard P, Falissard B, Journois D.

Clin J Am Soc Nephrol. 2014 Feb;9(2):285-94. doi: 10.2215/CJN.04730513. Epub 2013 Nov 21.

5.

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).

Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, Bossuyt X, Boutten A, Bienvenu J, Duquesne A, Richer O, Chaussabel D, Mogenet A, Banchereau J, Treluyer JM, Landais P, Pascual V.

Ann Rheum Dis. 2011 May;70(5):747-54. doi: 10.1136/ard.2010.134254. Epub 2010 Dec 20.

6.

High levels and safety of oseltamivir carboxylate plasma concentrations after nasogastric administration in critically ill children in a pediatric intensive care unit.

Giraud C, Manceau S, Oualha M, Chappuy H, Mogenet A, Duchêne P, Ducrocq S, Hubert P, Treluyer JM.

Antimicrob Agents Chemother. 2011 Jan;55(1):433-5. doi: 10.1128/AAC.00813-10. Epub 2010 Oct 11.

7.

Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.

Sermet-Gaudelus I, Boeck KD, Casimir GJ, Vermeulen F, Leal T, Mogenet A, Roussel D, Fritsch J, Hanssens L, Hirawat S, Miller NL, Constantine S, Reha A, Ajayi T, Elfring GL, Miller LL.

Am J Respir Crit Care Med. 2010 Nov 15;182(10):1262-72. doi: 10.1164/rccm.201001-0137OC. Epub 2010 Jul 9.

PMID:
20622033
8.

Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.

Bonnefont JP, Bastin J, Laforêt P, Aubey F, Mogenet A, Romano S, Ricquier D, Gobin-Limballe S, Vassault A, Behin A, Eymard B, Bresson JL, Djouadi F.

Clin Pharmacol Ther. 2010 Jul;88(1):101-8. doi: 10.1038/clpt.2010.55. Epub 2010 May 26.

PMID:
20505667
9.

Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.

Bisiaux A, Thiounn N, Timsit MO, Eladaoui A, Chang HH, Mapes J, Mogenet A, Bresson JL, Prié D, Béchet S, Baron C, Sadorge C, Thomas S, Albert EB, Albert PS, Albert ML.

J Urol. 2009 Apr;181(4):1571-80. doi: 10.1016/j.juro.2008.11.124. Epub 2009 Feb 23.

PMID:
19230924
10.

Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders.

Laroche F, Ramoz N, Leroy S, Fortin C, Rousselot-Paillet B, Philippe A, Colleaux L, Bresson JL, Mogenet A, Golse B, Mouren-Simeoni MC, Gorwood P, Galli T, Simonneau M, Krebs MO, Robel L.

Psychiatr Genet. 2008 Dec;18(6):295-301. doi: 10.1097/YPG.0b013e3283060fa5.

PMID:
19018235
11.

Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial.

Blanchard A, Vargas-Poussou R, Peyrard S, Mogenet A, Baudouin V, Boudailliez B, Charbit M, Deschesnes G, Ezzhair N, Loirat C, Macher MA, Niaudet P, Azizi M.

Am J Kidney Dis. 2008 Dec;52(6):1084-95. doi: 10.1053/j.ajkd.2008.08.021. Epub 2008 Oct 30.

PMID:
18976849
12.

Fate and effects of Camembert cheese micro-organisms in the human colonic microbiota of healthy volunteers after regular Camembert consumption.

Firmesse O, Alvaro E, Mogenet A, Bresson JL, Lemée R, Le Ruyet P, Bonhomme C, Lambert D, Andrieux C, Doré J, Corthier G, Furet JP, Rigottier-Gois L.

Int J Food Microbiol. 2008 Jul 15;125(2):176-81. doi: 10.1016/j.ijfoodmicro.2008.03.044. Epub 2008 Apr 14.

PMID:
18554738
13.

Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults.

Rochet V, Rigottier-Gois L, Ledaire A, Andrieux C, Sutren M, Rabot S, Mogenet A, Bresson JL, Cools S, Picard C, Goupil-Feuillerat N, Doré J.

J Mol Microbiol Biotechnol. 2008;14(1-3):128-36.

PMID:
17957120
14.
15.

Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.

Bachelot A, Laborde K, Bresson JL, Plu-Bureau G, Raynaud A, Bertagna X, Mogenet A, Mansour M, Lucas-Jouy V, Gayno JP, Reznik Y, Kuhn JM, Billaud L, Vacher-Lavenu MC, Putterman M, Mowszowicz I, Touraine P, Kuttenn F.

J Endocrinol Invest. 2007 Sep;30(8):636-46.

PMID:
17923794
16.

Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease.

de Montalembert M, Bachir D, Hulin A, Gimeno L, Mogenet A, Bresson JL, Macquin-Mavier I, Roudot-Thoraval F, Astier A, Galactéros F.

Haematologica. 2006 Dec;91(12):1685-8.

17.

Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk.

Oozeer R, Leplingard A, Mater DD, Mogenet A, Michelin R, Seksek I, Marteau P, Doré J, Bresson JL, Corthier G.

Appl Environ Microbiol. 2006 Aug;72(8):5615-7.

18.

A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.

Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, Durand-Zaleski I, Ghez D, Dal Cortivo L, Piesvaux P, Cavazzana-Calvo M, Varet B.

Haematologica. 2006 Apr;91(4):550-3.

19.

Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans.

Rochet V, Rigottier-Gois L, Sutren M, Krementscki MN, Andrieux C, Furet JP, Tailliez P, Levenez F, Mogenet A, Bresson JL, Méance S, Cayuela C, Leplingard A, Doré J.

Br J Nutr. 2006 Feb;95(2):421-9.

PMID:
16469162
20.

Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt.

Mater DD, Bretigny L, Firmesse O, Flores MJ, Mogenet A, Bresson JL, Corthier G.

FEMS Microbiol Lett. 2005 Sep 15;250(2):185-7.

21.

Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes.

Le Feuvre CL, Barthélémy O, Dubois-Laforgue D, Maunoury Ch, Mogenet A, Baubion N, Metzger JP, Timsit J.

Diabetes Metab. 2005 Apr;31(2):135-42.

PMID:
15959419
22.

Cumulative adverse effects of diabetes mellitus and hypertension on coronary flow velocity reserve.

Le Feuvre C, Raoux F, Beygui F, Helft G, Mogenet A, Dubois-Laforgue D, Timsit J, Metzger JP.

Arch Mal Coeur Vaiss. 2004 Sep;97(9):849-54.

PMID:
15521476
23.

Glucocorticoid pharmacokinetics and growth retardation in children with renal transplants.

Chavatte C, Guest G, Proust V, Le Bihan C, Gimenez F, Maisin A, Loirat C, Mogenet A, Bresson JL, Hankard R, Broyer M, Niaudet P, Singlas E.

Pediatr Nephrol. 2004 Aug;19(8):898-904. Epub 2004 Jun 3.

PMID:
15197639
24.

Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.

De Leersnyder H, Bresson JL, de Blois MC, Souberbielle JC, Mogenet A, Delhotal-Landes B, Salefranque F, Munnich A.

J Med Genet. 2003 Jan;40(1):74-8. No abstract available.

25.

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

Chaillous L, Lefèvre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Maréchaud R, Bougnères P, Charbonnel B, Saï P.

Lancet. 2000 Aug 12;356(9229):545-9.

PMID:
10950231
26.

Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.

Deschamps I, Boitard C, Hors J, Busson M, Marcelli-Barge A, Mogenet A, Robert JJ.

Diabetologia. 1992 Oct;35(10):951-7.

PMID:
1451952
27.
28.

[Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].

Robert JJ, Boitard C, Mogenet A, Chevenne D, Roger M, Deschamps I.

Arch Fr Pediatr. 1991 Jan;48(1):11-7. French.

PMID:
2018414

Supplemental Content

Loading ...
Support Center